Preclinical Data
Artemis Therapeutics Announces Two Recent Publications Highlighting Artemisone's Activity Against Human Cytomegalovirus And Malaria
Artemis Therapeutics
PR-M06-18-NI-063Jun 20, 2018
Clinical Data
New Data Demonstrate Artemis Therapeutics' Artemisone May Be An Effective Inhibitor Of Human CMV Replication
Artemis Therapeutics
PR-M06-18-NI-030Jun 11, 2018
Drug Development
New Malaria Therapeutic Receives FDA Orphan Drug Designation
Nice Insight
PAO-M11-17-NI-028Nov 16, 2017